New injection targets chronic back pain in early trial

NCT ID NCT07520240

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests a single injection of ITX24-01 in 32 adults with severe chronic facet joint pain in the neck or lower back. The main goal is to see if the drug is safe and tolerable compared to a placebo. Researchers will also look for early signs of pain relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ITX24-01

What this could lead to

If it works, this could point toward a new treatment for severe chronic neck and lower back pain caused by facet joints.

What could go wrong

This is a very early Phase 1b trial with only 32 participants, so it is primarily checking safety, not effectiveness. The treatment may not reduce pain or could cause side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACET JOINT PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Back Pain Neck Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sydney Pain Management Centre

    Wahroonga, New South Wales, 2076, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact